Literature DB >> 178832

Peripheral nerve changes induced by methyl n-butyl ketone and potentiation by methyl ethyl ketone.

K Saida, J R Mendell, H S Weiss.   

Abstract

A study of the sequential morphological changes in the peripheral nerve induced by experimental inhalation exposure of methyl n-butyl ketone (MBK) revealed that the earliest change was an increase in the number of neurofilaments in the large myelinated nerve fibers. This change occurred prior to axonal swelling or myelin thinning. As the duration of exposure lengthened the number of neurofilaments gradually increased and ultimately produced axonal swelling with secondary thinning of the myelin sheath. This appears to be the pathogenesis of the "giant axonal" neuropathy. Another change observed early in this neuropathy was the presence of inpouchings of the myelin sheath, which also increased in number in parallel to the duration of exposure. A careful study of the sequential changes in the entire motor unit did not show a predilection for early morphological changes at the axon terminal. Abnormalities at the neuromuscular junction occurred only after a full spectrum of changes were seen in the main nerve trunk, nerve roots and intramuscular nerves. An important observation was the marked potentiation of peripheral neurotoxicity observed when animals were exposed to MBK in combination with methyl ethyl ketone (MEK) at a ratio of 1:5, MBK:MEK. The latter solvent showed no neurotoxic effect alone. This might help explain a recent outbreak of a polyneuropathy affecting many workers. One further observation was that the sural nerve of a patient with prolonged exposure to MBK showed changes similar to those induced experimentally.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 178832     DOI: 10.1097/00005072-197605000-00001

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  27 in total

1.  Autonomic and peripheral nervous system dysfunction in workers exposed to mixed organic solvents.

Authors:  K Murata; S Araki; K Yokoyama; K Maeda
Journal:  Int Arch Occup Environ Health       Date:  1991       Impact factor: 3.015

2.  Giant axonal neuropathy. Involvement of peripheral nerve, myenteric plexus and extra-neuronal area.

Authors:  D Gambarelli; J Hassoun; J F Pellissier; M O Livet; N Pinsard; M Toga
Journal:  Acta Neuropathol       Date:  1977-08-31       Impact factor: 17.088

3.  An electrophysiological follow up of patients with n-hexane polyneuropathy.

Authors:  Y C Chang
Journal:  Br J Ind Med       Date:  1991-01

4.  Experimental alcoholic neuropathy in the rat: histological and electrophysiological study on the myoneural junctions and the peripheral nerves.

Authors:  J Juntunen; H Teräväinen; K Eriksson; P Panula; A Larsen
Journal:  Acta Neuropathol       Date:  1978-02-20       Impact factor: 17.088

5.  Neurotoxic properties of certain aliphatic hexacarbons.

Authors:  P S Spencer; H H Schaumburg
Journal:  Proc R Soc Med       Date:  1977-01

6.  Sural nerve biopsies from workers with a history of chronic exposure to organic solvents and from normal control cases. Morphometric and ultrastructural studies.

Authors:  C H Berthold; C Nordborg; C Hildebrand; S Conradi; P Sourander; H Lugnegård
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

7.  An experimental study on the combined effects of n-hexane and toluene on the peripheral nerve of the rat.

Authors:  Y Takeuchi; Y Ono; N Hisanaga
Journal:  Br J Ind Med       Date:  1981-02

8.  Experimental study on the enhancement of the neurotoxicity of methyl n-butyl ketone by non-neurotoxic aliphatic monoketones.

Authors:  J Misumi; M Nagano
Journal:  Br J Ind Med       Date:  1985-03

9.  Giant axonal neuropathy: possibly secondary to vitamin b12 malabsorption.

Authors:  S S Schochet; A L Chesson
Journal:  Acta Neuropathol       Date:  1977-09-26       Impact factor: 17.088

10.  Serum cholinesterase inhibitors in the commercial hexane impurities.

Authors:  E Vilanova; J L Vicedo
Journal:  Arch Toxicol       Date:  1983-05       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.